SCHEMBL28340700

SCHEMBL28340700

[CH2]NC(C)C(O)c1ccccc1

nearest known ligand 0.67

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ADRA2C P18825 2/20 0.67
▸ CYP2D6 P10635 2/20 0.67
▸ CYP2C19 P33261 2/20 0.67
▸ CHRM2 P08172 1/20 0.67
▸ ADRA1A P35348 1/20 0.67
▸ RGS12 O14924 1/20 0.67
▸ GLA P06280 1/20 0.67
▸ CYP3A4 P08684 1/20 0.67
▸ CYP2C9 P11712 1/20 0.67
▸ PKM P14618 1/20 0.67
▸ ALOX15 P16050 1/20 0.67
▸ TSHR P16473 1/20 0.67
▸ ALOX12 P18054 1/20 0.67
▸ NFKB1 P19838 1/20 0.67
▸ HTR2A P28223 1/20 0.67
▸ THPO P40225 1/20 0.67
▸ GNAI1 P63096 1/20 0.67
▸ HSD17B10 Q99714 1/20 0.67
▸ KMT2A Q03164 2/20 0.64
▸ MEN1 O00255 1/20 0.64

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4713568 0.81 ADRA1A (0.54) ADRA2CCYP2D6CYP2C19CHRM2ADRA1A
Pseudoephedrine SCHEMBL4368 0.80 CYP2D6 (1.00) ADRA2CCYP2D6CYP2C19CHRM2ADRA1A
Racephedrine SCHEMBL11906521 0.80 CYP2D6 (1.00) ADRA2CCYP2D6CYP2C19CHRM2ADRA1A
Racephedrine SCHEMBL12573578 0.80 CYP2D6 (1.00) ADRA2CCYP2D6CYP2C19CHRM2ADRA1A
Racephedrine SCHEMBL4369 0.80 CYP2D6 (1.00) ADRA2CCYP2D6CYP2C19CHRM2ADRA1A
Ephedrine SCHEMBL4731265 0.80 CYP2D6 (1.00) ADRA2CCYP2D6CYP2C19CHRM2ADRA1A
Racephedrine SCHEMBL8098202 0.80 CYP2D6 (1.00) ADRA2CCYP2D6CYP2C19CHRM2ADRA1A
Racephedrine SCHEMBL4786 0.80 CYP2D6 (1.00) ADRA2CCYP2D6CYP2C19CHRM2ADRA1A
Ephedrine SCHEMBL4785 0.80 CYP2D6 (1.00) ADRA2CCYP2D6CYP2C19CHRM2ADRA1A
Ephedrine SCHEMBL30411556 0.80 CYP2D6 (1.00) ADRA2CCYP2D6CYP2C19CHRM2ADRA1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-110668988-A Azetidines as MEK inhibitors for the treatment of proliferative diseases 埃克塞利希斯股份有限公司 2020-01-10 — — CN disclosed
Send feedback